Michelle Hastings is pioneering RNA-based therapies at Michigan Medicine, developing treatments for rare genetic diseases that are already making their way to patients. As the leader of the cutting-edge RNA Therapeutics initiative, she’s helping to redefine what’s possible in modern medicine. Discover how her work could change the way we treat disease.
